WO1999034743A1 - Method and apparatus for monitoring solid tissue heating - Google Patents
Method and apparatus for monitoring solid tissue heating Download PDFInfo
- Publication number
- WO1999034743A1 WO1999034743A1 PCT/US1999/000424 US9900424W WO9934743A1 WO 1999034743 A1 WO1999034743 A1 WO 1999034743A1 US 9900424 W US9900424 W US 9900424W WO 9934743 A1 WO9934743 A1 WO 9934743A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- impedance
- power supply
- power
- baseline
- light elements
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1477—Needle-like probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00875—Resistance or impedance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1405—Electrodes having a specific shape
- A61B2018/1425—Needle
Definitions
- the present invention is related to U.S. Patent Application Serial No. 08/936,294, filed on September 25, 1997 (Attorney Docket No. 16807-000900) and U.S. Patent Application Serial No. 08/858,414, filed on May 19, 1997 (Attorney Docket No. 16807-001000) .
- the full, disclosure of these applications are incorporated herein by reference.
- the present invention relates generally to the use of radio frequency energy for heating and necrosing solid tissue. More particularly, the present invention relates to a control method and system for delivering radio frequency current to the tissue through an electrode or electrode array disposed within the tissue.
- radio frequency energy may be delivered to diseased regions in target tissue for the purpose of tissue heating and/or necrosis, referred to generally as hyperthermia.
- the liver is a common depository for metastases of many primary cancers, such as cancers of the stomach, bowel, pancreas, kidney and lung.
- Electrosurgical probes for deploying single and multiple electrodes have been designed for the treatment and necrosis of tumors in the liver and other solid tissues. See, for example, the references cited in the Description of the Background Art hereinafter.
- a primary goal in such hyperthermic treatments, particularly those intended for tumor treatment, is the complete, thorough, and uniform heating of the target tissue mass.
- Uniform heating of the tissue mass can be difficult to achieve, particularly in highly vascularized tissues where variability in local blood flow can have a significant effect on the heating characteristics of the tissue. For example, creation of a lesion having a selected volume in some highly perfused tissue locations may require twice as much power as an identically-sized lesion in less highly perfused locations. While a variety of approaches for achieving such complete, thorough, and uniform heating of tissue have been proposed, most such approaches are somewhat complex and require the use of electrodes which are capable of measuring temperature, or the like. See, for example, the radio frequency power supply described in published PCT Application WO 93/08757.
- the methods, systems, and apparatus should be simple to implement and use, and should preferably reduce the complexity, cost, and treatment time required to achieve complete heating and/or necrosis of the target tissue mass.
- the methods, systems, and apparatus should preferably require no information or feedback from the tissue region being treated, other than information which can be acquired from the power delivery characteristics which can be monitored in the radio frequency power delivery system itself.
- the methods, systems, and apparatus should be able to operate solely by monitoring the power and/or current delivery characteristics of the radio frequency energy into an electrode system present in the target tissue.
- monitoring information will be presented in an intuitive manner on a display coupled to or near the power delivery system. At least some of these objective will be met by the present invention as claimed hereinafter.
- WO 97/06739; WO 97/06740; WO 97/06855; and WO 97/06857 describe RF treatment electrodes and note that power delivery can "impede out” if levels of power delivered are raised too high.
- Assignee of the present application has developed a radio frequency power supply (Model RF-2000, RadioTherapeutics Corporation, Mountain View, California) which provides power levels up to 100 W and is intended for the coagulation (ablation) of soft tissue.
- the power supply is controlled by a programmable microprocessor which is capable of continuously monitoring power delivered to an electrode system.
- Patents and published applications describing radio frequency tissue ablation using electrodes having various configurations include U.S. Patent Nos. 5,662,680; 5,599,346; 5,599,345; 5,562,703; 5,536,267; 5,489,161; 5,472,441; and 5,458,597; and published International Applications WO 97/06857; WO 97/06855; WO 97/06740; WO 97/06739; WO 96/04860; and WO 95/13113.
- a radio frequency power supply having impedance monitoring capability is described in WO 93/08757.
- the present invention provides improved methods and apparatus for monitoring the delivery of radio frequency (RF) energy from electrodes disposed in tissue for inducing hyperthermia and other purposes. It has been found that the delivery of radio frequency power to electrode (s) disposed in tissue can, if the power is delivered for a sufficient time and/or at a sufficient power delivery level or flux, result in an abrupt increase in the electrical impedance between the electrode (s) and tissue.
- RF radio frequency
- the present invention relies on the occurrence of the abrupt reduction in power delivery (which may be observed as a reduction in current delivery to the electrodes) to provide information about the heat capacity and heat delivery characteristics of the local target tissue region. Such information is used to control subsequent delivery of energy to the target tissue region using the same electrode (s) .
- a power supply for use in RF tissue ablation is provided with a unique impedance display which enables the user to concurrently perform the methods described in the co- pending U.S. Patent Application Serial No. 08/936,294, filed on September 25, 1997 (Attorney Docket No. 16807-000900) .
- the power supply comprises a radio frequency power source having a power output, a power return, a voltage signal, and a current signal.
- the power supply has means for calculating impedance within the target tissue based on the voltage and current signals.
- the power supply provides an impedance display electronically coupled to the calculating means.
- the display typically has an image of a bar graph where the bar graph changes in length in response to changes in calculated impedance .
- the display may be a flat panel display or some other type of display device.
- the impedance display comprises of an array of discrete light elements, where the number of light elements illuminated with respect to a baseline increases in response to an increase in calculated impedance .
- the baseline will be measured and assigned some number of elements which will be illuminated.
- the activation and deactivation of light elements is in response to changes, usually percentage changes, relative to the baseline impedance.
- the array of light elements is typically arranged in a non-linear pattern where a left hand portion of the array extends horizontally while a right hand portion curves upwardly .
- the radio frequency energy is supplied as a radio frequency current using a controlled voltage or constant voltage power supply.
- the use of such radio frequency power sources is preferred because the limited voltage available necessarily results in a reduction of current when the electrode/tissue impedance rises.
- the limited voltage also decreases the likelihood of arcing or sparking from the electrode into the tissue.
- the power supply will be operated at a level which depends on the size of the electrode, the target tissue type, and the degree of tissue perfusion.
- the power supply will provide power in the range from 10 W to 200 W, during all phases of the above-described methods.
- the electrodes will generally be energized at a power between 20 and 100 W which is in the range from 50% to 90% of the local maximum power level, usually from 70% to 80%.
- a method for providing impedance information to an operator comprises the steps of measuring a baseline level of impedance and displaying an image of a length of a bar graph, where the length represents the baseline level of impedance.
- the changes in impedance are measured, and the length of the bar graph is changed in response to measured changes in impedance.
- the displaying step may comprise illuminating a number of individual light elements of an array of discrete light elements, where the number represents the baseline level of impedance. Changes in impedance are displayed by changing the number of illuminated light elements. For example, a predetermined number of light elements are lit to represent a baseline value of impedance.
- the number of illuminated light elements are increased if impedance increases by about 2 to 10% and decreased if the number of light elements if impedance decreases by about 5 to 20%.
- the percentage increases or decreases required to activate or deactivate a light element may be altered as desired to provide the optimal resolution and/or smoothing of impedance changes displayed.
- Fig. 1 is a flow chart illustrating the method steps for radio frequency surgery which may be implemented manually or as part of an automatic control system.
- Fig. 2 is a flow chart illustrating an exemplary method for determining a treatment power level which may be implemented as part of the general method illustrated in Fig. 1.
- Fig. 3 is a schematic of a system according to the present invention for radio frequency surgery.
- Fig. 4 is a schematic view of a power supply according to the present invention.
- Fig. 5 shows an exemplary embodiment of an impedance display according to the present invention.
- Fig. 6 is a graph of power and impedance levels encountered during an radio frequency surgical procedure .
- Treatments according to the present invention will usually be effected by passing a radio frequency current through the target tissue region in a monopolar or bipolar manner.
- the specific electrode probes and methods described hereinafter illustrate a monopolar application of radio frequency current to the patient, where a treatment electrode is positioned in the target tissue and a passive or dispersive "electrode" is disposed against the patient's skin to complete a return path for the radio frequency circuit being created.
- a type of monopolar operation may be employed where the dispersive return electrode is mounted on a portion of the electrode probe being used for treatment . In that case, the area of the dispersive electrode is maximized in order to decrease any heating effect which might occur from current flux at the return electrode.
- the methods of the present invention can employ bipolar treatment where paired treatment electrodes are employed to both form the complete circuit and to heat the tissue therebetween.
- the desired radio frequency power is preferably supplied at a frequency in the range from 300 kHz to 1.2 MHz, with a conventional sinusoidal or non-sinusoidal wave form.
- a power supply of the present invention described below will operate with a fixed or controlled voltage so that power and current diminish with an increase in observed impedance.
- Preferred power supplies will operate at relatively low fixed voltages, typically below 150 V (peak-to- peak) , usually being from 50 V to 100 V will be preferred.
- Such radio frequency power supplies are available from RadioTherapeutics Corporation, assignee of the present application, as well as other commercial supplies. In all cases, current will be selected to provide an operating power generally in the range from 10 W to 100 W, usually have a sinusoidal wave form, but optionally having other wave forms.
- the power delivered will depend on the current and the impedance present in the circuit.
- methods for RF treatment will begin with delivering power at levels which do not result in excessive electrode/ tissue interface impedances until the tissue is fully necrosed.
- power/current may be increased resulting in a more rapid heating of the tissue.
- rapid heating will induce a hard or abrupt increase in the impedance between the tissue electrodes and the adjacent tissue, as previously described.
- the power supply operates at a constant voltage and in both cases will thus be unable to maintain current levels through the increased tissue impedance. Power is substantially reduced as current drops off since power falls as the square of the decrease in current .
- RF energy treatment will be generally described. Such methods will rely on energizing tissue electrodes disposed within tissue to heat the tissue for a variety of hyperthermic therapeutic purposes.
- the electrode (s) will be energized with radio frequency current generally within the power ranges set forth above . Initially, the electrode (s) will be energized at a power P 0 , with an initial energization lasting long enough to establish a base tissue temperature, which may either be constant or may be gradually increasing, i.e. at a rate less than about 10°C/min., usually less than about 5°C.
- the electrode energization will then be increased above the initial power level P 0 , by either a rapid increase or gradual increase protocol as described in more detail below.
- the level of power delivered to the tissue will eventually cause an abrupt increase in the impedance between the electrode (s) and the adjacent tissue, which in turn results in observation of an abrupt decrease in the power delivered to the electrode (s) .
- both the decrease in power and the change in impedance is calculable by measuring the current and voltage delivered from the power supply itself. Thus, there is no need to measure impedance, temperature, or any other characteristics directly within the patient tissue or at the electrode/tissue interface. Power at which such decrease occurs is defined herein as the maximum power P- v ⁇ .
- the abrupt increase in impedance and decrease in power delivered to the electrode (s) is dependent on a number of factors such as tissue type, the degree of local blood perfusion, and the tissue temperature prior to the power increase. In all cases, at the local value of PMAX, the abrupt impedance increase/power decrease will occur over a very short period of time, typically in the range from 10 seconds to 20 seconds.
- the increase in impedance results from the formation of a thin layer of gas over the electrodes which begins as discrete, isolated bubble (s) at particular sites on the electrode surface. Surprisingly, such local bubble formation quickly spreads over most or all of the electrode surface area so that the power delivered to the electrodes quickly drops to a uniformly low density.
- power delivered to the tissue will be reduced, typically by an amount in the range from 70% to 95%, usually in the range from 85% to 95%, based on the initial power level P 0 .
- Determination of the maximum power level is useful in a variety of ways to determine an appropriate treatment power level, as described in more detail below. It is believed that a power limiting impedance typically results from a very thin gaseous layer formed over all or a portion of the electrode surface, and it is further believed that cessation of energization allows the thin gaseous layer to cool very rapidly and to dissipate.
- the radio frequency power source will be completely de-energized for a period of time sufficient to permit the bubble layer to dissipate and the tissue impedance to return to its low impedance condition, typically from 3 seconds to 20 seconds, usually from 5 seconds to
- the energization of the electrode (s) will be restored at a power level selected to maximize delivery of radio frequency energy to the target tissue without prematurely terminating treatment due to the high impedance/low power delivery condition described above. In some cases, however, it will be desirable to optionally repeat the intentional inducement of the high impedance/low power delivery state in order to further optimize power delivery, as discussed in more detail below.
- a first preferred protocol for inducing the abrupt impedance increase/power decrease and determining a desired treatment power level is described.
- Power being delivered to the tissue electrodes is increased at a controlled rate, typically in the range from 1 W/min. to
- the power is preferably increased linearly at a specific rate within these ranges via a linear increase in voltage until the impedance increases.
- Actual power delivered to the electrode is monitored, either visually by the operator or automatically by a control system. At some point, which may occur from 2 minutes to 10 minutes after initiating the power increase, usually occurring from 3 minutes to 5 minutes after the initiation of the power increase, the impedance at the electrode-tissue interface will abruptly increase, causing a decrease in the level of power being delivered to the electrodes .
- the power which was delivered to the electrodes immediately prior to the abrupt decrease is considered to be the maximum power (P-IAX) deliverable to the electrodes for that particular treatment location.
- the subsequent treatment power level can thus be determined as a fraction or percentage of the maximum power P ⁇ , typically being from 50% to 90% of P MAX ' preferably from 70% to 75% of P-y ⁇ .
- Fig. 2 The particular protocol illustrated in Fig. 2 is desirable in its simplicity. It can readily be implemented manually, i.e. without the use of an automatic digital controller, by an operator gradually increasing the delivered power rate by manually adjusting the power supply (either continuously or more usually in shortly spaced increments within the ranges set forth above) , but is also suitable for automatic implementation.
- Other suitable protocols for RF surgery are described in U.S. Patent Application Serial No. 08/936,294, filed on September 25, 1997 (Attorney Docket No. 16807-000900) , the full disclosure of which has been incorporated herein by reference .
- a probe system 100 for use in the above described protocol includes a cannula 102 and a plurality of individual electrodes 104 constrained within the cannula over the outer cylindrical surface of a core member 106.
- the cannula 102 is only partly illustrated with a proximal length broken-off .
- the entire cannula will typically have a length in the range from about 5 cm to 30 cm, preferably from 10 cm to 20 cm, and outer diameter in the range from 1 mm to 5 mm, preferably from 1.3 mm to 4 mm, and an inner diameter in the range from 0.7 mm to 4 mm, preferably from 1 mm to 3.5 mm.
- the cannula may be formed from metals, plastics, or the like, and may be electrically active or inactive within the probe system 100, depending on the manner in which electrical energy is to be applied.
- Electrodes 104 are connected at their proximal ends to a reciprocatable shaft 122.
- the core 106 is also secured to the distal end of cylindrical block 120 so that the core and electrodes move together as the shaft 122 is advanced distally or retracted proximally relative to the cannula 102.
- the core 106 moves with the electrodes, it will be appreciated that the core will enter the tissue at the same time as the electrodes 104.
- the core 106 is shown to have a sharpened distal end 124 to enhance tissue penetration.
- the core 106 may be electrically coupled to the electrodes 104 (in which case it acts as an additional electrode of the same polarity as electrodes 104) or may be electrically isolated from the electrodes. When the core is electrically isolated, it can remain neutral during a treatment protocol, or alternatively it may be energized in the opposite polarity and thus act as a return electrode in a bipolar treatment protocol.
- a connector 140 at the proximal end of shaft 122 may then be connected to an electrosurgical power supply 200. Suitable power supplies are available from commercial suppliers as listed above.
- a second connecting cable 190 extends from the electrosurgical power supply 200 to a dispersive plate electrode (not shown) on the patient for monopolar operation.
- the invention can be. adapted for use with a variety of other RF surgical instruments. Variations of the above described system such as variations in design, location of RF power connections, software operation and structure, specific algorithms used in some software subroutines, configuration of RF probes, and other modifications are possible. II • Power Supply
- an electrosurgical power supply 200 of the present invention will preferably have adjustable power outputs , typically by varying the voltage to set current and power, and will permit monitoring of the actual power and calculated electrode/tissue impedance delivered to the electrodes being used to treat the patient.
- the power supply 200 can deliver at least 80 watts to the probe system 100, more preferably at least 90 watts, and most preferably at least 100 watts.
- the methods may be performed manually, i.e. by an operator manually adjusting the power levels and observing the electrode/tissue impedance and power deliveries on a conventional power supply.
- the power supply may be used with a digital controller which may be incorporated within the electrosurgical power supply 200, situated between the electrosurgical power supply and the patient, or which may be interfaced with a properly equipped power supply.
- a computer interfaced with a power supply is illustrated in Fig. 3.
- the power supply 200 will also usually include a monitoring/control interface .
- the computer PC may employ any operating system compatible with the electrosurgical power supply 200, the computer will typically be interfaced using a conventional cable.
- the methods of the present invention may be delivered to the personal computer PC and thus to the electrosurgical power supply 200 by programming the computer in any conventional manner.
- a floppy disk D or other computer memory component may be used in order to implement the program within the computer.
- Any other manner of delivering computer readable code and instructions into the computer may also be utilized, including compact disk, tape, read only memory (ROM) , and delivery of instructions via a modem and/or over the internet.
- An exemplary power supply having the power and computer interface capabilities suitable for the present invention is the Model RF-2000 (shown in Fig. 4) , available from RadioTherapeutics Corporation, Mountain View, California, assignee of the present application. III . Power Supply Display
- a power supply 200 having an impedance display 210 allows an operator to visually monitor impedance changes encountered by the probe system 100.
- the impedance display 210 on the power supply includes an image of a bar graph 211 which increases or decreases in length in response to changes in calculated impedance.
- the display may use flat panel displays such as a liquid crystal display (LCD) or other types of devices such as cathode ray tube monitors to show the operator the real time level of impedance. The operator may use this information to adjust the level of power delivery from the supply 200 as desired.
- LCD liquid crystal display
- the display 210 comprises of an array of discrete light elements 212, such as an array of light emitting diodes (LEDs) , arranged in a nonlinear pattern.
- the nonlinear pattern of the array of discrete light elements 212 preferably defines a line or a segmented bar graph where the left hand portion of the array is horizontal and the right hand portion curves upwardly.
- four light elements 212 comprise the horizontal portion while seven light elements 212 comprise the upwardly curved portion.
- the curved right hand portion created by the light elements 212 mimics the shape of an x-y plot of impedance versus time.
- the display 210 does not need to be directly connected to the power supply 200 and may be a separate standalone unit .
- the power supply 200 obtains impedance information by sensing output RF voltage signal and output RF current signal from a power outlet 220.
- a processor 230 calculates the impedance based on the voltage and current signals from the power outlet 220 and a power return 240.
- the impedance encountered by the probe system 100 may be derived by dividing the voltage by the current. Impedance measurements are made across a patient-isolation boundary using medically-isolated voltage and current sensors known in the art. This presently measured impedance is then compared, typically by processor 230, to an initial or baseline impedance value to calculate whether the bar graph 211 should be lengthened or shortened to reflect changes in measured impedance. In a preferred embodiment, the lengthening and shortening of the bar graph 211 involves the illumination or deillumination of individual light elements 212.
- a small amount of power is applied to the probe system 100 to measure an initial, or baseline impedance in the system.
- the small amount of power typically 1 watt or more, is supplied to the system 100, and the baseline impedance calculated.
- the calculated impedance is then treated as the baseline for all subsequent impedance determinations.
- the baseline is initially displayed as a predetermined length of the bar graph 211.
- a predetermined number of discrete light elements 212 typically four horizontal elements
- the display 210 are illuminated to represent the baseline impedance (regardless of the actual value of the baseline) . This establishes an initial point of visual reference for the operator during the procedure.
- Changes in the impedance calculated by the system 100 within the target tissue causes changes in the length of the bar graph 211 or the number of illuminated light elements 212.
- the percentage change in impedance required to increase or decrease the length of the bar graph 211, or the number of illuminated light elements 212 is graduated to keep the rate of change of the bar graph fairly smooth as the RF treatment proceeds .
- the power supply 200 when the four horizontal elements 212 are illuminated, it takes about a 5 to 20%, preferably 10% or more, drop in impedance for at least one of the illuminated light elements to go out.
- an increase of about 2 to 10%, preferably 5% or more illuminates at least the next discrete light element 212.
- the number of light elements 212 responding to changes in impedance may also be varied.
- the operator may use the impedance information displayed on the display 210 to either decide when to shut off or reduce power to the probe system 100 as described in Fig. 1.
- the power level and impedance levels for a typical liver ablation procedure is shown in Fig. 6.
- the display 210 is used for monitoring and observational purposes.
Abstract
The present invention provides improved methods and apparatus for monitoring the delivery of radio frequency (RF) energy from electrodes disposed in tissue for inducing hyperthermia, and other purposes. In one embodiment, an impedance display (210) of a power supply (200) comprises an array of discrete light elements (212), where the number of light elements (212) illuminated increases in response to a percentage increase in calculated impedance. The array of light elements (212) is typically arranged in a non-linear pattern where a left hand portion of the array extends horizontally while a right hand portion extends upwardly. The display allows an operator to visually monitor abrupt increases in impedance between an RF instrument, and a target tissue. Such increases are used to determine acceptable power ranges to achieve a maximum sustainable delivery of radio frequency energy to the tissue consistent with complete, rapid, and uniform heating of the tissue.
Description
METHOD AND APPARATUS FOR MONITORING SOLID TISSUE HEATING
CROSS-REFERENCE TO RELATED APPLICATIONS
The present invention is related to U.S. Patent Application Serial No. 08/936,294, filed on September 25, 1997 (Attorney Docket No. 16807-000900) and U.S. Patent Application Serial No. 08/858,414, filed on May 19, 1997 (Attorney Docket No. 16807-001000) . The full, disclosure of these applications are incorporated herein by reference.
BACKGROUND OF THE INVENTION 1. Field of the Invention
The present invention relates generally to the use of radio frequency energy for heating and necrosing solid tissue. More particularly, the present invention relates to a control method and system for delivering radio frequency current to the tissue through an electrode or electrode array disposed within the tissue.
The delivery of radio frequency energy to target regions within solid tissue is known for a variety of purposes. Of particular interest to the present invention, radio frequency energy may be delivered to diseased regions in target tissue for the purpose of tissue heating and/or necrosis, referred to generally as hyperthermia. For example, the liver is a common depository for metastases of many primary cancers, such as cancers of the stomach, bowel, pancreas, kidney and lung. Electrosurgical probes for deploying single and multiple electrodes have been designed for the treatment and necrosis of tumors in the liver and other solid tissues. See, for example, the references cited in the Description of the Background Art hereinafter.
A primary goal in such hyperthermic treatments, particularly those intended for tumor treatment, is the complete, thorough, and uniform heating of the target tissue mass. Uniform heating of the tissue mass, however, can be difficult to achieve, particularly in highly vascularized tissues where variability in local blood flow can have a significant effect on the heating characteristics of the tissue. For example, creation of a lesion having a selected volume in some highly perfused tissue locations may require twice as much power as an identically-sized lesion in less highly perfused locations. While a variety of approaches for achieving such complete, thorough, and uniform heating of tissue have been proposed, most such approaches are somewhat complex and require the use of electrodes which are capable of measuring temperature, or the like. See, for example, the radio frequency power supply described in published PCT Application WO 93/08757. In general, many approaches for achieving uniform tissue heating have relied on slow, gradual heating of the tissue in order to avoid the formation of steam or charred or otherwise necrosed tissue which results in high radio frequency impedance regions within the target tissue mass. Such approaches, however, are complex, can result in an undesirable prolongation of the treatment, and are not always successful . For these reasons, it would be desirable to provide improved treatment methods, systems, and apparatus which allow for effective and efficient delivery of a radio frequency energy to solid tissue masses using electrodes. In particular, it would be desirable to provide such methods, systems, and apparatus which are useful with many or all tissue-penetrating electrode systems which are now available or which might become available in the future. The methods, systems, and apparatus should be simple to implement and use, and should preferably reduce the complexity, cost, and treatment time required to achieve complete heating and/or necrosis of the target tissue mass. The methods, systems, and apparatus should preferably require no information or feedback from the tissue region being treated, other than information
which can be acquired from the power delivery characteristics which can be monitored in the radio frequency power delivery system itself. In particular, the methods, systems, and apparatus should be able to operate solely by monitoring the power and/or current delivery characteristics of the radio frequency energy into an electrode system present in the target tissue. Preferably, monitoring information will be presented in an intuitive manner on a display coupled to or near the power delivery system. At least some of these objective will be met by the present invention as claimed hereinafter.
2. Description of the Background Art The heating of solid tissue with radio frequency current using the preferred electrode structures of the present invention is described in WO 96/29946 and co-pending Applications Serial Nos . 08/410,344; 08/559,072; 08/766,154; 08/764,085; and 08/858,414, filed on May 19, 1997, the full disclosures of which are incorporated herein by reference.
WO 97/06739; WO 97/06740; WO 97/06855; and WO 97/06857 describe RF treatment electrodes and note that power delivery can "impede out" if levels of power delivered are raised too high. Assignee of the present application has developed a radio frequency power supply (Model RF-2000, RadioTherapeutics Corporation, Mountain View, California) which provides power levels up to 100 W and is intended for the coagulation (ablation) of soft tissue. The power supply is controlled by a programmable microprocessor which is capable of continuously monitoring power delivered to an electrode system.
Patents and published applications describing radio frequency tissue ablation using electrodes having various configurations include U.S. Patent Nos. 5,662,680; 5,599,346; 5,599,345; 5,562,703; 5,536,267; 5,489,161; 5,472,441; and 5,458,597; and published International Applications WO 97/06857; WO 97/06855; WO 97/06740; WO 97/06739; WO 96/04860; and WO 95/13113.
A radio frequency power supply having impedance monitoring capability is described in WO 93/08757.
Other radio frequency power apparatus and methods are described in U.S. Patent Nos. 5,556,396; 5,514,129; 5,496,312; 5,437,664; and 5,370,645; and WO 95/20360, WO 95/09577, and WO 95/20360.
SUMMARY OF THE INVENTION The present invention provides improved methods and apparatus for monitoring the delivery of radio frequency (RF) energy from electrodes disposed in tissue for inducing hyperthermia and other purposes. It has been found that the delivery of radio frequency power to electrode (s) disposed in tissue can, if the power is delivered for a sufficient time and/or at a sufficient power delivery level or flux, result in an abrupt increase in the electrical impedance between the electrode (s) and tissue. While such an abrupt increase in impedance is undesirable since it results in an immediate fall-off of energy delivery (for a voltage limited radio frequency power source) , the present invention relies on the occurrence of the abrupt reduction in power delivery (which may be observed as a reduction in current delivery to the electrodes) to provide information about the heat capacity and heat delivery characteristics of the local target tissue region. Such information is used to control subsequent delivery of energy to the target tissue region using the same electrode (s) .
As described in co-pending U.S. Patent Application Serial No. 08/936,294, filed on September 25, 1997 (Attorney Docket No. 16807-000900) , an abrupt rise in the electrode- tissue interface impedance diminishes very rapidly when the power delivery is stopped, typically disappearing within several seconds . Delivery of the radio frequency power can be resumed after the impedance has diminished, typically to impedance levels substantially equal to those observed prior to the abrupt increase. Based on these observations, it is possible to determine improved or optimized radio frequency
power delivery levels and protocols based on the power levels and/or time periods required to induce the abrupt impedance increases and associated power declines in specific target locations. In particular, the protocols rely on appropriate adjustments to the power levels which are resumed after the tissue impedance diminishes.
In a first particular aspect of the present invention, a power supply for use in RF tissue ablation is provided with a unique impedance display which enables the user to concurrently perform the methods described in the co- pending U.S. Patent Application Serial No. 08/936,294, filed on September 25, 1997 (Attorney Docket No. 16807-000900) . The power supply comprises a radio frequency power source having a power output, a power return, a voltage signal, and a current signal. The power supply has means for calculating impedance within the target tissue based on the voltage and current signals. To provide feedback to the operator on instrument- tissue interface impedance, the power supply provides an impedance display electronically coupled to the calculating means. The display typically has an image of a bar graph where the bar graph changes in length in response to changes in calculated impedance . The display may be a flat panel display or some other type of display device.
In one embodiment, the impedance display comprises of an array of discrete light elements, where the number of light elements illuminated with respect to a baseline increases in response to an increase in calculated impedance . The baseline will be measured and assigned some number of elements which will be illuminated. The activation and deactivation of light elements is in response to changes, usually percentage changes, relative to the baseline impedance. The array of light elements is typically arranged in a non-linear pattern where a left hand portion of the array extends horizontally while a right hand portion curves upwardly .
In general, the radio frequency energy is supplied as a radio frequency current using a controlled voltage or constant voltage power supply. The use of such radio
frequency power sources is preferred because the limited voltage available necessarily results in a reduction of current when the electrode/tissue impedance rises. In addition to allowing the monitoring of impedance based on observing the power or current delivered to the electrodes, the limited voltage also decreases the likelihood of arcing or sparking from the electrode into the tissue. Usually, the power supply will be operated at a level which depends on the size of the electrode, the target tissue type, and the degree of tissue perfusion. Typically, the power supply will provide power in the range from 10 W to 200 W, during all phases of the above-described methods. For prolonged treatment, the electrodes will generally be energized at a power between 20 and 100 W which is in the range from 50% to 90% of the local maximum power level, usually from 70% to 80%.
In a second aspect of the present invention, a method for providing impedance information to an operator comprises the steps of measuring a baseline level of impedance and displaying an image of a length of a bar graph, where the length represents the baseline level of impedance. As the procedure proceeds, the changes in impedance are measured, and the length of the bar graph is changed in response to measured changes in impedance. In one embodiment, the displaying step may comprise illuminating a number of individual light elements of an array of discrete light elements, where the number represents the baseline level of impedance. Changes in impedance are displayed by changing the number of illuminated light elements. For example, a predetermined number of light elements are lit to represent a baseline value of impedance. The number of illuminated light elements are increased if impedance increases by about 2 to 10% and decreased if the number of light elements if impedance decreases by about 5 to 20%. The percentage increases or decreases required to activate or deactivate a light element may be altered as desired to provide the optimal resolution and/or smoothing of impedance changes displayed.
A further understanding of the nature and advantages of the invention may be realized by reference to the remaining portions of the specification and the drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 is a flow chart illustrating the method steps for radio frequency surgery which may be implemented manually or as part of an automatic control system. Fig. 2 is a flow chart illustrating an exemplary method for determining a treatment power level which may be implemented as part of the general method illustrated in Fig. 1.
Fig. 3 is a schematic of a system according to the present invention for radio frequency surgery.
Fig. 4 is a schematic view of a power supply according to the present invention.
Fig. 5 shows an exemplary embodiment of an impedance display according to the present invention. Fig. 6 is a graph of power and impedance levels encountered during an radio frequency surgical procedure .
DESCRIPTION OF THE SPECIFIC EMBODIMENTS I . Overview of Radio Frequency Treatment
Treatments according to the present invention will usually be effected by passing a radio frequency current through the target tissue region in a monopolar or bipolar manner. The specific electrode probes and methods described hereinafter illustrate a monopolar application of radio frequency current to the patient, where a treatment electrode is positioned in the target tissue and a passive or dispersive "electrode" is disposed against the patient's skin to complete a return path for the radio frequency circuit being created. Alternatively, a type of monopolar operation may be employed where the dispersive return electrode is mounted on a portion of the electrode probe being used for treatment . In that case, the area of the dispersive electrode is maximized in
order to decrease any heating effect which might occur from current flux at the return electrode. Further alternatively, the methods of the present invention can employ bipolar treatment where paired treatment electrodes are employed to both form the complete circuit and to heat the tissue therebetween.
The desired radio frequency power is preferably supplied at a frequency in the range from 300 kHz to 1.2 MHz, with a conventional sinusoidal or non-sinusoidal wave form. Preferably, a power supply of the present invention described below will operate with a fixed or controlled voltage so that power and current diminish with an increase in observed impedance. Preferred power supplies will operate at relatively low fixed voltages, typically below 150 V (peak-to- peak) , usually being from 50 V to 100 V will be preferred. Such radio frequency power supplies are available from RadioTherapeutics Corporation, assignee of the present application, as well as other commercial supplies. In all cases, current will be selected to provide an operating power generally in the range from 10 W to 100 W, usually have a sinusoidal wave form, but optionally having other wave forms.
It will be appreciated that with a fixed or controlled voltage, the power delivered will depend on the current and the impedance present in the circuit. Generally, as described in detail below, methods for RF treatment will begin with delivering power at levels which do not result in excessive electrode/ tissue interface impedances until the tissue is fully necrosed. At some point in the treatment protocols of the present invention, power/current may be increased resulting in a more rapid heating of the tissue. In such a case, rapid heating will induce a hard or abrupt increase in the impedance between the tissue electrodes and the adjacent tissue, as previously described. The power supply operates at a constant voltage and in both cases will thus be unable to maintain current levels through the increased tissue impedance. Power is substantially reduced as current drops off since power falls as the square of the decrease in current .
Referring now to Fig. 1, methods for RF energy treatment will be generally described. Such methods will rely on energizing tissue electrodes disposed within tissue to heat the tissue for a variety of hyperthermic therapeutic purposes. The electrode (s) will be energized with radio frequency current generally within the power ranges set forth above . Initially, the electrode (s) will be energized at a power P0, with an initial energization lasting long enough to establish a base tissue temperature, which may either be constant or may be gradually increasing, i.e. at a rate less than about 10°C/min., usually less than about 5°C. The electrode energization will then be increased above the initial power level P0, by either a rapid increase or gradual increase protocol as described in more detail below. In both protocols, the level of power delivered to the tissue will eventually cause an abrupt increase in the impedance between the electrode (s) and the adjacent tissue, which in turn results in observation of an abrupt decrease in the power delivered to the electrode (s) . Conveniently, both the decrease in power and the change in impedance is calculable by measuring the current and voltage delivered from the power supply itself. Thus, there is no need to measure impedance, temperature, or any other characteristics directly within the patient tissue or at the electrode/tissue interface. Power at which such decrease occurs is defined herein as the maximum power P-v^. The abrupt increase in impedance and decrease in power delivered to the electrode (s) is dependent on a number of factors such as tissue type, the degree of local blood perfusion, and the tissue temperature prior to the power increase. In all cases, at the local value of PMAX, the abrupt impedance increase/power decrease will occur over a very short period of time, typically in the range from 10 seconds to 20 seconds. The increase in impedance results from the formation of a thin layer of gas over the electrodes which begins as discrete, isolated bubble (s) at particular sites on the electrode surface. Surprisingly, such local bubble formation quickly spreads over most or all of the electrode surface area so that the power delivered to the
electrodes quickly drops to a uniformly low density. Thus, power delivered to the tissue will be reduced, typically by an amount in the range from 70% to 95%, usually in the range from 85% to 95%, based on the initial power level P0. Determination of the maximum power level is useful in a variety of ways to determine an appropriate treatment power level, as described in more detail below. It is believed that a power limiting impedance typically results from a very thin gaseous layer formed over all or a portion of the electrode surface, and it is further believed that cessation of energization allows the thin gaseous layer to cool very rapidly and to dissipate. Usually, the radio frequency power source will be completely de-energized for a period of time sufficient to permit the bubble layer to dissipate and the tissue impedance to return to its low impedance condition, typically from 3 seconds to 20 seconds, usually from 5 seconds to
10 seconds. It is not necessary, however, to completely shut off power so long as it is reduced sufficiently to allow the temperature and impedance to lower.
After the impedance has returned to its low impedance state, the energization of the electrode (s) will be restored at a power level selected to maximize delivery of radio frequency energy to the target tissue without prematurely terminating treatment due to the high impedance/low power delivery condition described above. In some cases, however, it will be desirable to optionally repeat the intentional inducement of the high impedance/low power delivery state in order to further optimize power delivery, as discussed in more detail below.
Referring now to Fig. 2, a first preferred protocol for inducing the abrupt impedance increase/power decrease and determining a desired treatment power level is described. Power being delivered to the tissue electrodes is increased at a controlled rate, typically in the range from 1 W/min. to
25 W/min., preferably from 10 W/min. to 15 W/min. The power is preferably increased linearly at a specific rate within these ranges via a linear increase in voltage until the
impedance increases. Actual power delivered to the electrode is monitored, either visually by the operator or automatically by a control system. At some point, which may occur from 2 minutes to 10 minutes after initiating the power increase, usually occurring from 3 minutes to 5 minutes after the initiation of the power increase, the impedance at the electrode-tissue interface will abruptly increase, causing a decrease in the level of power being delivered to the electrodes . The power which was delivered to the electrodes immediately prior to the abrupt decrease is considered to be the maximum power (P-IAX) deliverable to the electrodes for that particular treatment location. The subsequent treatment power level can thus be determined as a fraction or percentage of the maximum power P^^, typically being from 50% to 90% of P MAX' preferably from 70% to 75% of P-y^.
The particular protocol illustrated in Fig. 2 is desirable in its simplicity. It can readily be implemented manually, i.e. without the use of an automatic digital controller, by an operator gradually increasing the delivered power rate by manually adjusting the power supply (either continuously or more usually in shortly spaced increments within the ranges set forth above) , but is also suitable for automatic implementation. Other suitable protocols for RF surgery are described in U.S. Patent Application Serial No. 08/936,294, filed on September 25, 1997 (Attorney Docket No. 16807-000900) , the full disclosure of which has been incorporated herein by reference .
Referring now to Fig. 3, a probe system 100 for use in the above described protocol includes a cannula 102 and a plurality of individual electrodes 104 constrained within the cannula over the outer cylindrical surface of a core member 106. The cannula 102 is only partly illustrated with a proximal length broken-off . The entire cannula will typically have a length in the range from about 5 cm to 30 cm, preferably from 10 cm to 20 cm, and outer diameter in the range from 1 mm to 5 mm, preferably from 1.3 mm to 4 mm, and an inner diameter in the range from 0.7 mm to 4 mm, preferably from 1 mm to 3.5 mm. The cannula may be formed from metals,
plastics, or the like, and may be electrically active or inactive within the probe system 100, depending on the manner in which electrical energy is to be applied.
Electrodes 104 are connected at their proximal ends to a reciprocatable shaft 122. The core 106 is also secured to the distal end of cylindrical block 120 so that the core and electrodes move together as the shaft 122 is advanced distally or retracted proximally relative to the cannula 102. As the core 106 moves with the electrodes, it will be appreciated that the core will enter the tissue at the same time as the electrodes 104. Thus, the core 106 is shown to have a sharpened distal end 124 to enhance tissue penetration. The core 106 may be electrically coupled to the electrodes 104 (in which case it acts as an additional electrode of the same polarity as electrodes 104) or may be electrically isolated from the electrodes. When the core is electrically isolated, it can remain neutral during a treatment protocol, or alternatively it may be energized in the opposite polarity and thus act as a return electrode in a bipolar treatment protocol.
A connector 140 at the proximal end of shaft 122 may then be connected to an electrosurgical power supply 200. Suitable power supplies are available from commercial suppliers as listed above. A second connecting cable 190 extends from the electrosurgical power supply 200 to a dispersive plate electrode (not shown) on the patient for monopolar operation.
The probe system description presented above is mainly for general illustrative purposes and should not be considered as limiting the scope of the present invention.
That is, the invention can be. adapted for use with a variety of other RF surgical instruments. Variations of the above described system such as variations in design, location of RF power connections, software operation and structure, specific algorithms used in some software subroutines, configuration of RF probes, and other modifications are possible.
II • Power Supply
Referring to Fig. 4, an electrosurgical power supply 200 of the present invention will preferably have adjustable power outputs , typically by varying the voltage to set current and power, and will permit monitoring of the actual power and calculated electrode/tissue impedance delivered to the electrodes being used to treat the patient. The power supply 200 can deliver at least 80 watts to the probe system 100, more preferably at least 90 watts, and most preferably at least 100 watts. The methods may be performed manually, i.e. by an operator manually adjusting the power levels and observing the electrode/tissue impedance and power deliveries on a conventional power supply.
Optionally, but not necessarily, the power supply may be used with a digital controller which may be incorporated within the electrosurgical power supply 200, situated between the electrosurgical power supply and the patient, or which may be interfaced with a properly equipped power supply. The use of a computer interfaced with a power supply is illustrated in Fig. 3. The power supply 200 will also usually include a monitoring/control interface . The computer PC may employ any operating system compatible with the electrosurgical power supply 200, the computer will typically be interfaced using a conventional cable. The methods of the present invention may be delivered to the personal computer PC and thus to the electrosurgical power supply 200 by programming the computer in any conventional manner. A floppy disk D or other computer memory component may be used in order to implement the program within the computer. Any other manner of delivering computer readable code and instructions into the computer may also be utilized, including compact disk, tape, read only memory (ROM) , and delivery of instructions via a modem and/or over the internet. An exemplary power supply having the power and computer interface capabilities suitable for the present invention is the Model RF-2000 (shown in Fig. 4) , available from RadioTherapeutics Corporation, Mountain View, California, assignee of the present application.
III . Power Supply Display
Referring now to Figs . 4 and 5 , an impedance display 210 for use with an electrosurgical power supply 200 will now be described. A power supply 200 having an impedance display 210 allows an operator to visually monitor impedance changes encountered by the probe system 100. The impedance display 210 on the power supply includes an image of a bar graph 211 which increases or decreases in length in response to changes in calculated impedance. The display may use flat panel displays such as a liquid crystal display (LCD) or other types of devices such as cathode ray tube monitors to show the operator the real time level of impedance. The operator may use this information to adjust the level of power delivery from the supply 200 as desired.
In a preferred embodiment, the display 210 comprises of an array of discrete light elements 212, such as an array of light emitting diodes (LEDs) , arranged in a nonlinear pattern. Although not limited in this manner, the nonlinear pattern of the array of discrete light elements 212 preferably defines a line or a segmented bar graph where the left hand portion of the array is horizontal and the right hand portion curves upwardly. In a specific preferred embodiment, four light elements 212 comprise the horizontal portion while seven light elements 212 comprise the upwardly curved portion. The curved right hand portion created by the light elements 212 mimics the shape of an x-y plot of impedance versus time. This upwardly curving shape accentuates the change in level much more than if the bar simply extended in a straight line. This makes the interpretation of the display 210 more intuitive to the operator. Such a display is also more visible and easily understood by the physician or other operator who will typically be standing five to ten feet away from the power supply during use . It should also be understood that the display 210 does not need to be directly connected to the power supply 200 and may be a separate standalone unit .
In the exemplary embodiment, the power supply 200 obtains impedance information by sensing output RF voltage signal and output RF current signal from a power outlet 220. A processor 230 calculates the impedance based on the voltage and current signals from the power outlet 220 and a power return 240. The impedance encountered by the probe system 100 may be derived by dividing the voltage by the current. Impedance measurements are made across a patient-isolation boundary using medically-isolated voltage and current sensors known in the art. This presently measured impedance is then compared, typically by processor 230, to an initial or baseline impedance value to calculate whether the bar graph 211 should be lengthened or shortened to reflect changes in measured impedance. In a preferred embodiment, the lengthening and shortening of the bar graph 211 involves the illumination or deillumination of individual light elements 212.
As described above, during typical radio frequency surgical procedures, a small amount of power is applied to the probe system 100 to measure an initial, or baseline impedance in the system. The small amount of power, typically 1 watt or more, is supplied to the system 100, and the baseline impedance calculated. The calculated impedance is then treated as the baseline for all subsequent impedance determinations. The baseline is initially displayed as a predetermined length of the bar graph 211. In embodiments using discrete light elements 212, a predetermined number of discrete light elements 212 (typically four horizontal elements) on the display 210 are illuminated to represent the baseline impedance (regardless of the actual value of the baseline) . This establishes an initial point of visual reference for the operator during the procedure. Changes in the impedance calculated by the system 100 within the target tissue causes changes in the length of the bar graph 211 or the number of illuminated light elements 212.
Preferably, the percentage change in impedance required to increase or decrease the length of the bar graph 211, or the number of illuminated light elements 212, is
graduated to keep the rate of change of the bar graph fairly smooth as the RF treatment proceeds . For example in one embodiment of the power supply 200, when the four horizontal elements 212 are illuminated, it takes about a 5 to 20%, preferably 10% or more, drop in impedance for at least one of the illuminated light elements to go out. However, an increase of about 2 to 10%, preferably 5% or more, illuminates at least the next discrete light element 212. The number of light elements 212 responding to changes in impedance may also be varied. Although not limited in this manner, it may be necessary in some scenarios for multiple light elements 212 to be illuminated or deilluminated with each change in impedance. As observed in Fig. 6, the changes in the impedance shown by line 250 are nonlinear and may require this graduated illumination or scaling to provide proper resolution to display the impedance changes occurring during the procedure . It should be understood that the percentage change in impedance required to light or unlight each element 212 or change the length of the bar graph 211 may be customized to provide the desired level of resolution for various radio frequency surgical procedures .
The operator may use the impedance information displayed on the display 210 to either decide when to shut off or reduce power to the probe system 100 as described in Fig. 1. The power level and impedance levels for a typical liver ablation procedure is shown in Fig. 6. Alternatively, in situations where the power supplied to the system 100 is automatically controlled, the display 210 is used for monitoring and observational purposes. While the above is a complete description of the preferred embodiments of the invention, various alternatives, modifications, and equivalents may be used. Therefore, the above description should not be taken as limiting the scope of the invention which is defined by the appended claims.
Claims
1. A power supply comprising: a radio frequency power source having a power output, a power return, a voltage signal, and a current signal; means for calculating impedance based on the voltage and current signals; and an impedance display electronically coupled to said means for calculating impedance, said display having an image of a bar graph wherein said graph changes in length in response to changes in calculated impedance.
2. A power supply as in claim 1 wherein said impedance display is a flat panel display.
3. A power supply as in claim 1 wherein the bar graph comprises a segmented bar graph.
4. A power supply as in claim 1 wherein the image of the bar graph comprises an array of discrete light elements, wherein the number of light elements illuminated increases in response to an increase in calculated impedance.
5. A power supply as in claim 4 wherein the light elements in the array are arranged in a non-linear pattern.
6. A power supply as in claim 5 wherein a left hand portion of the array is horizontal and the right hand portion curves upwardly.
7. A power supply as in claim 1 further comprising means for determining a baseline impedance and subsequent changes in impedance relative to the baseline, wherein the display changes the bar graph length based on the relative changes in impedance to reflect a change between a baseline impedance and a presently measured impedance.
8. A power supply as in claim 7 wherein the bar graph comprises discrete light elements and the supply further comprises means for determining the number of discrete light elements to illuminate to reflect the change between a baseline impedance and a presently measured impedance.
9. A method for providing impedance information to a operator of a radio frequency power supply comprising the steps of: measuring a baseline level of impedance; displaying an image of a length of a bar graph, wherein the length represents said baseline level of impedance ; measuring changes in impedance; and changing the length of the bar graph in response to measured changes in impedance.
10. A method as in claim 9 wherein: said baseline measuring step comprises measuring an initial impedance by applying a small amount of energy to a power output; measuring voltages across the power output and a power return; and dividing voltage by current to derive impedance .
11. A method as in claim 9 wherein: the displaying step comprises illuminating a number of individual light elements of an array of discrete light elements, wherein the number represents said baseline level of impedance ; said changing step comprises changing the number of illuminated light elements in response to measured changes in impedance .
12. A method as in claim 11 further comprising: lighting a predetermined number of light elements to represent a baseline value of impedance; illuminating at least one additional light element in response to an impedance increase of about 2 to 10% of the baseline impedance; and deilluminating at least one additional light element in response to an impedance decrease of about 5 to 20% of the baseline impedance .
13. A method as in claim 9 wherein the determining step comprises comparing a presently measured impedance value with the baseline level of impedance to calculate the percentage of the impedance display to illuminate.
14. A method for radio frequency surgery comprising the steps of: delivering radio frequency power to an electrode in tissue from a power supply; observing changes in electrode/tissue impedance relative to a baseline on a real time impedance display of the power supply; and decreasing power from the power supply when the impedance observed on the display exceeds a predetermined level .
15. An improved radio frequency power supply of the type having a radio frequency output and an impedance display, wherein the improvement comprises : a bar graph having a predetermined length which is displayed in response to a baseline impedance, wherein the graph changes in length in response to changes in measured impedance .
16. An improved power supply of claim 15 wherein: the bar graph comprises a curved bar graph of discrete light elements; wherein a number of light elements are illuminated in response to a baseline impedance and which the number of illuminated light elements changes in response to changes in measured impedance .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU21087/99A AU2108799A (en) | 1998-01-09 | 1999-01-07 | Method and apparatus for monitoring solid tissue heating |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/005,288 | 1998-01-09 | ||
US09/005,288 US6080149A (en) | 1998-01-09 | 1998-01-09 | Method and apparatus for monitoring solid tissue heating |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999034743A1 true WO1999034743A1 (en) | 1999-07-15 |
Family
ID=21715148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/000424 WO1999034743A1 (en) | 1998-01-09 | 1999-01-07 | Method and apparatus for monitoring solid tissue heating |
Country Status (3)
Country | Link |
---|---|
US (1) | US6080149A (en) |
AU (1) | AU2108799A (en) |
WO (1) | WO1999034743A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9050113B2 (en) | 2010-01-15 | 2015-06-09 | Medtronic Advanced Energy Llc | Electrosurgical devices, electrosurgical unit and methods of use thereof |
Families Citing this family (205)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6409722B1 (en) | 1998-07-07 | 2002-06-25 | Medtronic, Inc. | Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue |
US6634363B1 (en) * | 1997-04-07 | 2003-10-21 | Broncus Technologies, Inc. | Methods of treating lungs having reversible obstructive pulmonary disease |
US6358246B1 (en) * | 1999-06-25 | 2002-03-19 | Radiotherapeutics Corporation | Method and system for heating solid tissue |
US6313587B1 (en) | 1998-01-13 | 2001-11-06 | Fusion Lighting, Inc. | High frequency inductive lamp and power oscillator |
US7329253B2 (en) * | 2003-12-09 | 2008-02-12 | Rubicor Medical, Inc. | Suction sleeve and interventional devices having such a suction sleeve |
US7517348B2 (en) * | 1998-09-03 | 2009-04-14 | Rubicor Medical, Inc. | Devices and methods for performing procedures on a breast |
US6936014B2 (en) * | 2002-10-16 | 2005-08-30 | Rubicor Medical, Inc. | Devices and methods for performing procedures on a breast |
US6022362A (en) | 1998-09-03 | 2000-02-08 | Rubicor Medical, Inc. | Excisional biopsy devices and methods |
US6440147B1 (en) | 1998-09-03 | 2002-08-27 | Rubicor Medical, Inc. | Excisional biopsy devices and methods |
US6123702A (en) * | 1998-09-10 | 2000-09-26 | Scimed Life Systems, Inc. | Systems and methods for controlling power in an electrosurgical probe |
US7901400B2 (en) | 1998-10-23 | 2011-03-08 | Covidien Ag | Method and system for controlling output of RF medical generator |
US20040167508A1 (en) * | 2002-02-11 | 2004-08-26 | Robert Wham | Vessel sealing system |
US7364577B2 (en) | 2002-02-11 | 2008-04-29 | Sherwood Services Ag | Vessel sealing system |
US6796981B2 (en) | 1999-09-30 | 2004-09-28 | Sherwood Services Ag | Vessel sealing system |
US7137980B2 (en) | 1998-10-23 | 2006-11-21 | Sherwood Services Ag | Method and system for controlling output of RF medical generator |
JP4101951B2 (en) * | 1998-11-10 | 2008-06-18 | オリンパス株式会社 | Surgical microscope |
US6478793B1 (en) | 1999-06-11 | 2002-11-12 | Sherwood Services Ag | Ablation treatment of bone metastases |
AU6335400A (en) | 1999-07-02 | 2001-01-22 | Fusion Lighting, Inc. | High output lamp with high brightness |
US6638277B2 (en) | 2000-07-06 | 2003-10-28 | Scimed Life Systems, Inc. | Tumor ablation needle with independently activated and independently traversing tines |
US20020072739A1 (en) | 2000-12-07 | 2002-06-13 | Roberta Lee | Methods and devices for radiofrequency electrosurgery |
US6752804B2 (en) | 2000-12-28 | 2004-06-22 | Cardiac Pacemakers, Inc. | Ablation system and method having multiple-sensor electrodes to assist in assessment of electrode and sensor position and adjustment of energy levels |
US7008421B2 (en) * | 2002-08-21 | 2006-03-07 | Resect Medical, Inc. | Apparatus and method for tissue resection |
US6648883B2 (en) * | 2001-04-26 | 2003-11-18 | Medtronic, Inc. | Ablation system and method of use |
US7250048B2 (en) * | 2001-04-26 | 2007-07-31 | Medtronic, Inc. | Ablation system and method of use |
US7959626B2 (en) | 2001-04-26 | 2011-06-14 | Medtronic, Inc. | Transmural ablation systems and methods |
US6989010B2 (en) * | 2001-04-26 | 2006-01-24 | Medtronic, Inc. | Ablation system and method of use |
US6709380B2 (en) * | 2001-05-31 | 2004-03-23 | Neoseed Technology Llc | Brachytherapy needle with impedance measurement apparatus and methods of use |
US11229472B2 (en) | 2001-06-12 | 2022-01-25 | Cilag Gmbh International | Modular battery powered handheld surgical instrument with multiple magnetic position sensors |
US6630139B2 (en) * | 2001-08-24 | 2003-10-07 | Academia Sinica | Fibrinogenolytic proteases with thrombolytic and antihypertensive activities: medical application and novel process of expression and production |
WO2003092520A1 (en) | 2002-05-06 | 2003-11-13 | Sherwood Services Ag | Blood detector for controlling anesu and method therefor |
US7044956B2 (en) * | 2002-07-03 | 2006-05-16 | Rubicor Medical, Inc. | Methods and devices for cutting and collecting soft tissue |
US20040006355A1 (en) * | 2002-07-03 | 2004-01-08 | Rubicor Medical, Inc. | Methods and devices for cutting and collecting soft tissue |
US7223264B2 (en) * | 2002-08-21 | 2007-05-29 | Resect Medical, Inc. | Thermal coagulation of tissue during tissue resection |
US7106043B1 (en) * | 2002-09-17 | 2006-09-12 | Bioluminate, Inc. | Low capacitance measurement probe |
US7029451B2 (en) | 2002-11-06 | 2006-04-18 | Rubicor Medical, Inc. | Excisional devices having selective cutting and atraumatic configurations and methods of using same |
US20050119646A1 (en) * | 2002-11-13 | 2005-06-02 | Artemis Medical, Inc. | Devices and methods for controlling movement of an electrosurgical electrode |
JP2006506129A (en) * | 2002-11-13 | 2006-02-23 | アーテミス・メディカル・インコーポレイテッド | Apparatus and method for controlling initial operation of electrosurgical electrode |
US7044948B2 (en) | 2002-12-10 | 2006-05-16 | Sherwood Services Ag | Circuit for controlling arc energy from an electrosurgical generator |
US10172538B2 (en) | 2003-02-21 | 2019-01-08 | 3Dt Holdings, Llc | Body lumen junction localization |
US8078274B2 (en) | 2003-02-21 | 2011-12-13 | Dtherapeutics, Llc | Device, system and method for measuring cross-sectional areas in luminal organs |
US10413211B2 (en) | 2003-02-21 | 2019-09-17 | 3Dt Holdings, Llc | Systems, devices, and methods for mapping organ profiles |
US7722601B2 (en) | 2003-05-01 | 2010-05-25 | Covidien Ag | Method and system for programming and controlling an electrosurgical generator system |
US7122011B2 (en) * | 2003-06-18 | 2006-10-17 | Rubicor Medical, Inc. | Methods and devices for cutting and collecting soft tissue |
US8104956B2 (en) | 2003-10-23 | 2012-01-31 | Covidien Ag | Thermocouple measurement circuit |
AU2003284929B2 (en) | 2003-10-23 | 2010-07-22 | Covidien Ag | Redundant temperature monitoring in electrosurgical systems for safety mitigation |
US7396336B2 (en) | 2003-10-30 | 2008-07-08 | Sherwood Services Ag | Switched resonant ultrasonic power amplifier system |
US6958064B2 (en) * | 2003-11-14 | 2005-10-25 | Boston Scientific Scimed, Inc. | Systems and methods for performing simultaneous ablation |
US7131860B2 (en) | 2003-11-20 | 2006-11-07 | Sherwood Services Ag | Connector systems for electrosurgical generator |
US7766905B2 (en) | 2004-02-12 | 2010-08-03 | Covidien Ag | Method and system for continuity testing of medical electrodes |
US7780662B2 (en) | 2004-03-02 | 2010-08-24 | Covidien Ag | Vessel sealing system using capacitive RF dielectric heating |
US20050245920A1 (en) * | 2004-04-30 | 2005-11-03 | Vitullo Jeffrey M | Cell necrosis apparatus with cooled microwave antenna |
US7553309B2 (en) * | 2004-10-08 | 2009-06-30 | Covidien Ag | Electrosurgical system employing multiple electrodes and method thereof |
US7776035B2 (en) * | 2004-10-08 | 2010-08-17 | Covidien Ag | Cool-tip combined electrode introducer |
US7282049B2 (en) * | 2004-10-08 | 2007-10-16 | Sherwood Services Ag | Electrosurgical system employing multiple electrodes and method thereof |
US7628786B2 (en) | 2004-10-13 | 2009-12-08 | Covidien Ag | Universal foot switch contact port |
US7467075B2 (en) * | 2004-12-23 | 2008-12-16 | Covidien Ag | Three-dimensional finite-element code for electrosurgery and thermal ablation simulations |
US9474564B2 (en) | 2005-03-31 | 2016-10-25 | Covidien Ag | Method and system for compensating for external impedance of an energy carrying component when controlling an electrosurgical generator |
ITPD20050023U1 (en) * | 2005-04-12 | 2006-10-13 | Tsem Spa | BODY IMPEDENZIMETER |
US7655003B2 (en) | 2005-06-22 | 2010-02-02 | Smith & Nephew, Inc. | Electrosurgical power control |
US7615050B2 (en) * | 2005-06-27 | 2009-11-10 | Boston Scientific Scimed, Inc. | Systems and methods for creating a lesion using transjugular approach |
US7879031B2 (en) * | 2005-09-27 | 2011-02-01 | Covidien Ag | Cooled RF ablation needle |
US20070078454A1 (en) * | 2005-09-30 | 2007-04-05 | Mcpherson James W | System and method for creating lesions using bipolar electrodes |
US20070078453A1 (en) * | 2005-10-04 | 2007-04-05 | Johnson Kristin D | System and method for performing cardiac ablation |
US8734438B2 (en) | 2005-10-21 | 2014-05-27 | Covidien Ag | Circuit and method for reducing stored energy in an electrosurgical generator |
US20070100331A1 (en) * | 2005-10-27 | 2007-05-03 | Boston Scientific Scimed, Inc. | Systems and methods for organ tissue ablation |
US9333026B2 (en) | 2005-11-18 | 2016-05-10 | Boston Scientific Scimed, Inc. | Radio frequency lasso |
US7947039B2 (en) | 2005-12-12 | 2011-05-24 | Covidien Ag | Laparoscopic apparatus for performing electrosurgical procedures |
US8147485B2 (en) | 2006-01-24 | 2012-04-03 | Covidien Ag | System and method for tissue sealing |
US8685016B2 (en) | 2006-01-24 | 2014-04-01 | Covidien Ag | System and method for tissue sealing |
US7513896B2 (en) | 2006-01-24 | 2009-04-07 | Covidien Ag | Dual synchro-resonant electrosurgical apparatus with bi-directional magnetic coupling |
CA2574935A1 (en) | 2006-01-24 | 2007-07-24 | Sherwood Services Ag | A method and system for controlling an output of a radio-frequency medical generator having an impedance based control algorithm |
US8216223B2 (en) | 2006-01-24 | 2012-07-10 | Covidien Ag | System and method for tissue sealing |
CA2574934C (en) | 2006-01-24 | 2015-12-29 | Sherwood Services Ag | System and method for closed loop monitoring of monopolar electrosurgical apparatus |
CA2575392C (en) | 2006-01-24 | 2015-07-07 | Sherwood Services Ag | System and method for tissue sealing |
US9186200B2 (en) | 2006-01-24 | 2015-11-17 | Covidien Ag | System and method for tissue sealing |
US7651493B2 (en) | 2006-03-03 | 2010-01-26 | Covidien Ag | System and method for controlling electrosurgical snares |
US7648499B2 (en) | 2006-03-21 | 2010-01-19 | Covidien Ag | System and method for generating radio frequency energy |
US8795270B2 (en) * | 2006-04-24 | 2014-08-05 | Covidien Ag | System and method for ablating tissue |
US7651492B2 (en) | 2006-04-24 | 2010-01-26 | Covidien Ag | Arc based adaptive control system for an electrosurgical unit |
US20070255270A1 (en) * | 2006-04-27 | 2007-11-01 | Medtronic Vascular, Inc. | Intraluminal guidance system using bioelectric impedance |
US20070258838A1 (en) * | 2006-05-03 | 2007-11-08 | Sherwood Services Ag | Peristaltic cooling pump system |
US20070260240A1 (en) | 2006-05-05 | 2007-11-08 | Sherwood Services Ag | Soft tissue RF transection and resection device |
US8753334B2 (en) | 2006-05-10 | 2014-06-17 | Covidien Ag | System and method for reducing leakage current in an electrosurgical generator |
EP2092957B2 (en) | 2006-06-28 | 2019-11-20 | Medtronic Ardian Luxembourg S.à.r.l. | Systems for thermally-induced renal neuromodulation |
US7763018B2 (en) | 2006-07-28 | 2010-07-27 | Covidien Ag | Cool-tip thermocouple including two-piece hub |
US7731717B2 (en) | 2006-08-08 | 2010-06-08 | Covidien Ag | System and method for controlling RF output during tissue sealing |
US8034049B2 (en) | 2006-08-08 | 2011-10-11 | Covidien Ag | System and method for measuring initial tissue impedance |
US7794457B2 (en) | 2006-09-28 | 2010-09-14 | Covidien Ag | Transformer for RF voltage sensing |
JP5198466B2 (en) | 2006-12-06 | 2013-05-15 | ボストン サイエンティフィック リミテッド | Tissue ablation energy generator using pulse modulated radio frequency energy |
US8211099B2 (en) | 2007-01-31 | 2012-07-03 | Tyco Healthcare Group Lp | Thermal feedback systems and methods of using the same |
US20090187177A1 (en) * | 2008-01-28 | 2009-07-23 | Gordon Epstein | Impedance responsive ablation rf driving for moderating return electrode temperature |
US8777941B2 (en) | 2007-05-10 | 2014-07-15 | Covidien Lp | Adjustable impedance electrosurgical electrodes |
US9486269B2 (en) * | 2007-06-22 | 2016-11-08 | Covidien Lp | Electrosurgical systems and cartridges for use therewith |
US7834484B2 (en) | 2007-07-16 | 2010-11-16 | Tyco Healthcare Group Lp | Connection cable and method for activating a voltage-controlled generator |
US8181995B2 (en) * | 2007-09-07 | 2012-05-22 | Tyco Healthcare Group Lp | Cool tip junction |
US8216220B2 (en) | 2007-09-07 | 2012-07-10 | Tyco Healthcare Group Lp | System and method for transmission of combined data stream |
US8512332B2 (en) | 2007-09-21 | 2013-08-20 | Covidien Lp | Real-time arc control in electrosurgical generators |
US8292880B2 (en) | 2007-11-27 | 2012-10-23 | Vivant Medical, Inc. | Targeted cooling of deployable microwave antenna |
US8226639B2 (en) | 2008-06-10 | 2012-07-24 | Tyco Healthcare Group Lp | System and method for output control of electrosurgical generator |
US8608739B2 (en) * | 2008-07-22 | 2013-12-17 | Covidien Lp | Electrosurgical devices, systems and methods of using the same |
US9089360B2 (en) | 2008-08-06 | 2015-07-28 | Ethicon Endo-Surgery, Inc. | Devices and techniques for cutting and coagulating tissue |
US8333759B2 (en) * | 2009-01-12 | 2012-12-18 | Covidien Lp | Energy delivery algorithm for medical devices |
US8262652B2 (en) | 2009-01-12 | 2012-09-11 | Tyco Healthcare Group Lp | Imaginary impedance process monitoring and intelligent shut-off |
US8211100B2 (en) * | 2009-01-12 | 2012-07-03 | Tyco Healthcare Group Lp | Energy delivery algorithm for medical devices based on maintaining a fixed position on a tissue electrical conductivity v. temperature curve |
US8162932B2 (en) * | 2009-01-12 | 2012-04-24 | Tyco Healthcare Group Lp | Energy delivery algorithm impedance trend adaptation |
US8167875B2 (en) * | 2009-01-12 | 2012-05-01 | Tyco Healthcare Group Lp | Energy delivery algorithm for medical devices |
US20100256735A1 (en) * | 2009-04-03 | 2010-10-07 | Board Of Regents, The University Of Texas System | Intraluminal stent with seam |
US8663220B2 (en) | 2009-07-15 | 2014-03-04 | Ethicon Endo-Surgery, Inc. | Ultrasonic surgical instruments |
US11090104B2 (en) | 2009-10-09 | 2021-08-17 | Cilag Gmbh International | Surgical generator for ultrasonic and electrosurgical devices |
US10441345B2 (en) | 2009-10-09 | 2019-10-15 | Ethicon Llc | Surgical generator for ultrasonic and electrosurgical devices |
US8986302B2 (en) | 2009-10-09 | 2015-03-24 | Ethicon Endo-Surgery, Inc. | Surgical generator for ultrasonic and electrosurgical devices |
US8469981B2 (en) | 2010-02-11 | 2013-06-25 | Ethicon Endo-Surgery, Inc. | Rotatable cutting implement arrangements for ultrasonic surgical instruments |
US8419727B2 (en) * | 2010-03-26 | 2013-04-16 | Aesculap Ag | Impedance mediated power delivery for electrosurgery |
US8188435B2 (en) | 2010-06-03 | 2012-05-29 | Tyco Healthcare Group Lp | Specific absorption rate measurement and energy-delivery device characterization using thermal phantom and image analysis |
US9377367B2 (en) | 2010-06-03 | 2016-06-28 | Covidien Lp | Specific absorption rate measurement and energy-delivery device characterization using thermal phantom and image analysis |
US9241762B2 (en) | 2010-06-03 | 2016-01-26 | Covidien Lp | Specific absorption rate measurement and energy-delivery device characterization using image analysis |
US9468492B2 (en) | 2010-06-03 | 2016-10-18 | Covidien Lp | Specific absorption rate measurement and energy-delivery device characterization using image analysis |
US8795327B2 (en) | 2010-07-22 | 2014-08-05 | Ethicon Endo-Surgery, Inc. | Electrosurgical instrument with separate closure and cutting members |
US9192431B2 (en) | 2010-07-23 | 2015-11-24 | Ethicon Endo-Surgery, Inc. | Electrosurgical cutting and sealing instrument |
EP3449856B1 (en) | 2010-10-25 | 2023-06-28 | Medtronic Ardian Luxembourg S.à.r.l. | Device for evaluation and feedback of neuromodulation treatment |
US9259265B2 (en) | 2011-07-22 | 2016-02-16 | Ethicon Endo-Surgery, Llc | Surgical instruments for tensioning tissue |
US8814796B2 (en) | 2012-01-10 | 2014-08-26 | Hologic, Inc. | System and method for tissue ablation in a body cavity |
EP2811932B1 (en) | 2012-02-10 | 2019-06-26 | Ethicon LLC | Robotically controlled surgical instrument |
JP2015516846A (en) | 2012-04-05 | 2015-06-18 | バード・アクセス・システムズ,インコーポレーテッド | Device and system for navigating and positioning a central venous catheter within a patient |
US10159531B2 (en) | 2012-04-05 | 2018-12-25 | C. R. Bard, Inc. | Apparatus and methods relating to intravascular positioning of distal end of catheter |
US11759268B2 (en) | 2012-04-05 | 2023-09-19 | C. R. Bard, Inc. | Apparatus and methods relating to intravascular positioning of distal end of catheter |
US9439668B2 (en) | 2012-04-09 | 2016-09-13 | Ethicon Endo-Surgery, Llc | Switch arrangements for ultrasonic surgical instruments |
US9044238B2 (en) | 2012-04-10 | 2015-06-02 | Covidien Lp | Electrosurgical monopolar apparatus with arc energy vascular coagulation control |
US20140005705A1 (en) | 2012-06-29 | 2014-01-02 | Ethicon Endo-Surgery, Inc. | Surgical instruments with articulating shafts |
US9226767B2 (en) | 2012-06-29 | 2016-01-05 | Ethicon Endo-Surgery, Inc. | Closed feedback control for electrosurgical device |
US9408622B2 (en) | 2012-06-29 | 2016-08-09 | Ethicon Endo-Surgery, Llc | Surgical instruments with articulating shafts |
US9393037B2 (en) | 2012-06-29 | 2016-07-19 | Ethicon Endo-Surgery, Llc | Surgical instruments with articulating shafts |
US9351754B2 (en) | 2012-06-29 | 2016-05-31 | Ethicon Endo-Surgery, Llc | Ultrasonic surgical instruments with distally positioned jaw assemblies |
US9198714B2 (en) | 2012-06-29 | 2015-12-01 | Ethicon Endo-Surgery, Inc. | Haptic feedback devices for surgical robot |
US9326788B2 (en) | 2012-06-29 | 2016-05-03 | Ethicon Endo-Surgery, Llc | Lockout mechanism for use with robotic electrosurgical device |
US20140005702A1 (en) | 2012-06-29 | 2014-01-02 | Ethicon Endo-Surgery, Inc. | Ultrasonic surgical instruments with distally positioned transducers |
BR112015007010B1 (en) | 2012-09-28 | 2022-05-31 | Ethicon Endo-Surgery, Inc | end actuator |
US9095367B2 (en) | 2012-10-22 | 2015-08-04 | Ethicon Endo-Surgery, Inc. | Flexible harmonic waveguides/blades for surgical instruments |
US20140135804A1 (en) | 2012-11-15 | 2014-05-15 | Ethicon Endo-Surgery, Inc. | Ultrasonic and electrosurgical devices |
US20140309524A1 (en) | 2013-04-16 | 2014-10-16 | Transmed7, Llc | Methods, devices and therapeutic platform for automated, selectable, soft tissue resection |
US9872719B2 (en) | 2013-07-24 | 2018-01-23 | Covidien Lp | Systems and methods for generating electrosurgical energy using a multistage power converter |
US10285750B2 (en) * | 2013-07-29 | 2019-05-14 | Covidien Lp | Systems and methods for operating an electrosurgical generator |
US9636165B2 (en) | 2013-07-29 | 2017-05-02 | Covidien Lp | Systems and methods for measuring tissue impedance through an electrosurgical cable |
US9814514B2 (en) | 2013-09-13 | 2017-11-14 | Ethicon Llc | Electrosurgical (RF) medical instruments for cutting and coagulating tissue |
US10433902B2 (en) | 2013-10-23 | 2019-10-08 | Medtronic Ardian Luxembourg S.A.R.L. | Current control methods and systems |
US9265926B2 (en) | 2013-11-08 | 2016-02-23 | Ethicon Endo-Surgery, Llc | Electrosurgical devices |
GB2521228A (en) | 2013-12-16 | 2015-06-17 | Ethicon Endo Surgery Inc | Medical device |
US10004553B2 (en) | 2013-12-23 | 2018-06-26 | Hologic, Inc. | Power modulated endometrial lining tissue ablation |
US9795436B2 (en) | 2014-01-07 | 2017-10-24 | Ethicon Llc | Harvesting energy from a surgical generator |
US9554854B2 (en) | 2014-03-18 | 2017-01-31 | Ethicon Endo-Surgery, Llc | Detecting short circuits in electrosurgical medical devices |
US10092310B2 (en) | 2014-03-27 | 2018-10-09 | Ethicon Llc | Electrosurgical devices |
US10463421B2 (en) | 2014-03-27 | 2019-11-05 | Ethicon Llc | Two stage trigger, clamp and cut bipolar vessel sealer |
US9737355B2 (en) | 2014-03-31 | 2017-08-22 | Ethicon Llc | Controlling impedance rise in electrosurgical medical devices |
US9913680B2 (en) | 2014-04-15 | 2018-03-13 | Ethicon Llc | Software algorithms for electrosurgical instruments |
US10610292B2 (en) | 2014-04-25 | 2020-04-07 | Medtronic Ardian Luxembourg S.A.R.L. | Devices, systems, and methods for monitoring and/or controlling deployment of a neuromodulation element within a body lumen and related technology |
USD748803S1 (en) | 2014-06-26 | 2016-02-02 | Covidien Lp | Electrosurgical generator |
USD777772S1 (en) | 2014-06-26 | 2017-01-31 | Covidien Lp | Electrosurgical generator display screen with transitional graphical user interface |
US10285724B2 (en) | 2014-07-31 | 2019-05-14 | Ethicon Llc | Actuation mechanisms and load adjustment assemblies for surgical instruments |
US10194972B2 (en) * | 2014-08-26 | 2019-02-05 | Ethicon Llc | Managing tissue treatment |
US10639092B2 (en) | 2014-12-08 | 2020-05-05 | Ethicon Llc | Electrode configurations for surgical instruments |
US10245095B2 (en) | 2015-02-06 | 2019-04-02 | Ethicon Llc | Electrosurgical instrument with rotation and articulation mechanisms |
US10342602B2 (en) | 2015-03-17 | 2019-07-09 | Ethicon Llc | Managing tissue treatment |
US10321950B2 (en) | 2015-03-17 | 2019-06-18 | Ethicon Llc | Managing tissue treatment |
US10595929B2 (en) | 2015-03-24 | 2020-03-24 | Ethicon Llc | Surgical instruments with firing system overload protection mechanisms |
US10617463B2 (en) | 2015-04-23 | 2020-04-14 | Covidien Lp | Systems and methods for controlling power in an electrosurgical generator |
US11051873B2 (en) | 2015-06-30 | 2021-07-06 | Cilag Gmbh International | Surgical system with user adaptable techniques employing multiple energy modalities based on tissue parameters |
US11129669B2 (en) | 2015-06-30 | 2021-09-28 | Cilag Gmbh International | Surgical system with user adaptable techniques based on tissue type |
US10034704B2 (en) | 2015-06-30 | 2018-07-31 | Ethicon Llc | Surgical instrument with user adaptable algorithms |
US11141213B2 (en) | 2015-06-30 | 2021-10-12 | Cilag Gmbh International | Surgical instrument with user adaptable techniques |
US10898256B2 (en) | 2015-06-30 | 2021-01-26 | Ethicon Llc | Surgical system with user adaptable techniques based on tissue impedance |
US11033322B2 (en) | 2015-09-30 | 2021-06-15 | Ethicon Llc | Circuit topologies for combined generator |
US10595930B2 (en) | 2015-10-16 | 2020-03-24 | Ethicon Llc | Electrode wiping surgical device |
US10179022B2 (en) | 2015-12-30 | 2019-01-15 | Ethicon Llc | Jaw position impedance limiter for electrosurgical instrument |
US10575892B2 (en) | 2015-12-31 | 2020-03-03 | Ethicon Llc | Adapter for electrical surgical instruments |
US11229471B2 (en) | 2016-01-15 | 2022-01-25 | Cilag Gmbh International | Modular battery powered handheld surgical instrument with selective application of energy based on tissue characterization |
US11129670B2 (en) | 2016-01-15 | 2021-09-28 | Cilag Gmbh International | Modular battery powered handheld surgical instrument with selective application of energy based on button displacement, intensity, or local tissue characterization |
US11051840B2 (en) | 2016-01-15 | 2021-07-06 | Ethicon Llc | Modular battery powered handheld surgical instrument with reusable asymmetric handle housing |
US10716615B2 (en) | 2016-01-15 | 2020-07-21 | Ethicon Llc | Modular battery powered handheld surgical instrument with curved end effectors having asymmetric engagement between jaw and blade |
US10555769B2 (en) | 2016-02-22 | 2020-02-11 | Ethicon Llc | Flexible circuits for electrosurgical instrument |
US10702329B2 (en) | 2016-04-29 | 2020-07-07 | Ethicon Llc | Jaw structure with distal post for electrosurgical instruments |
US10646269B2 (en) | 2016-04-29 | 2020-05-12 | Ethicon Llc | Non-linear jaw gap for electrosurgical instruments |
US10485607B2 (en) | 2016-04-29 | 2019-11-26 | Ethicon Llc | Jaw structure with distal closure for electrosurgical instruments |
US10456193B2 (en) | 2016-05-03 | 2019-10-29 | Ethicon Llc | Medical device with a bilateral jaw configuration for nerve stimulation |
US10376305B2 (en) | 2016-08-05 | 2019-08-13 | Ethicon Llc | Methods and systems for advanced harmonic energy |
US11266430B2 (en) | 2016-11-29 | 2022-03-08 | Cilag Gmbh International | End effector control and calibration |
US11534226B2 (en) | 2017-09-22 | 2022-12-27 | Covidien Lp | Systems and methods for minimizing arcing of bipolar forceps |
US11272975B2 (en) | 2017-09-22 | 2022-03-15 | Covidien Lp | Systems and methods for controlled electrosurgical dissection |
US11744631B2 (en) | 2017-09-22 | 2023-09-05 | Covidien Lp | Systems and methods for controlled electrosurgical coagulation |
WO2019071269A2 (en) | 2017-10-06 | 2019-04-11 | Powell Charles Lee | System and method to treat obstructive sleep apnea |
US11812957B2 (en) | 2019-12-30 | 2023-11-14 | Cilag Gmbh International | Surgical instrument comprising a signal interference resolution system |
US11684412B2 (en) | 2019-12-30 | 2023-06-27 | Cilag Gmbh International | Surgical instrument with rotatable and articulatable surgical end effector |
US11452525B2 (en) | 2019-12-30 | 2022-09-27 | Cilag Gmbh International | Surgical instrument comprising an adjustment system |
US11911063B2 (en) | 2019-12-30 | 2024-02-27 | Cilag Gmbh International | Techniques for detecting ultrasonic blade to electrode contact and reducing power to ultrasonic blade |
US11779329B2 (en) | 2019-12-30 | 2023-10-10 | Cilag Gmbh International | Surgical instrument comprising a flex circuit including a sensor system |
US11786294B2 (en) | 2019-12-30 | 2023-10-17 | Cilag Gmbh International | Control program for modular combination energy device |
US11696776B2 (en) | 2019-12-30 | 2023-07-11 | Cilag Gmbh International | Articulatable surgical instrument |
US11937863B2 (en) | 2019-12-30 | 2024-03-26 | Cilag Gmbh International | Deflectable electrode with variable compression bias along the length of the deflectable electrode |
US11744636B2 (en) | 2019-12-30 | 2023-09-05 | Cilag Gmbh International | Electrosurgical systems with integrated and external power sources |
US20210196361A1 (en) | 2019-12-30 | 2021-07-01 | Ethicon Llc | Electrosurgical instrument with monopolar and bipolar energy capabilities |
US11779387B2 (en) | 2019-12-30 | 2023-10-10 | Cilag Gmbh International | Clamp arm jaw to minimize tissue sticking and improve tissue control |
US11786291B2 (en) | 2019-12-30 | 2023-10-17 | Cilag Gmbh International | Deflectable support of RF energy electrode with respect to opposing ultrasonic blade |
US11660089B2 (en) | 2019-12-30 | 2023-05-30 | Cilag Gmbh International | Surgical instrument comprising a sensing system |
US11937866B2 (en) | 2019-12-30 | 2024-03-26 | Cilag Gmbh International | Method for an electrosurgical procedure |
US11950797B2 (en) | 2019-12-30 | 2024-04-09 | Cilag Gmbh International | Deflectable electrode with higher distal bias relative to proximal bias |
US11944366B2 (en) | 2019-12-30 | 2024-04-02 | Cilag Gmbh International | Asymmetric segmented ultrasonic support pad for cooperative engagement with a movable RF electrode |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5423808A (en) * | 1991-11-08 | 1995-06-13 | Ep Technologies, Inc. | Systems and methods for radiofrequency ablation with phase sensitive power detection |
US5540681A (en) * | 1992-04-10 | 1996-07-30 | Medtronic Cardiorhythm | Method and system for radiofrequency ablation of tissue |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5370675A (en) * | 1992-08-12 | 1994-12-06 | Vidamed, Inc. | Medical probe device and method |
US5562703A (en) * | 1994-06-14 | 1996-10-08 | Desai; Ashvin H. | Endoscopic surgical instrument |
US5662680A (en) * | 1991-10-18 | 1997-09-02 | Desai; Ashvin H. | Endoscopic surgical instrument |
AU3067392A (en) * | 1991-11-08 | 1993-06-07 | Ep Technologies Inc | Systems and methods for ablating tissue while monitoring tissue impedance |
US5486161A (en) * | 1993-02-02 | 1996-01-23 | Zomed International | Medical probe device and method |
US5496312A (en) * | 1993-10-07 | 1996-03-05 | Valleylab Inc. | Impedance and temperature generator control |
US6210403B1 (en) * | 1993-10-07 | 2001-04-03 | Sherwood Services Ag | Automatic control for energy from an electrosurgical generator |
US5683384A (en) * | 1993-11-08 | 1997-11-04 | Zomed | Multiple antenna ablation apparatus |
US5458597A (en) * | 1993-11-08 | 1995-10-17 | Zomed International | Device for treating cancer and non-malignant tumors and methods |
US5599345A (en) * | 1993-11-08 | 1997-02-04 | Zomed International, Inc. | RF treatment apparatus |
US5472441A (en) * | 1993-11-08 | 1995-12-05 | Zomed International | Device for treating cancer and non-malignant tumors and methods |
US5536267A (en) * | 1993-11-08 | 1996-07-16 | Zomed International | Multiple electrode ablation apparatus |
US5514129A (en) * | 1993-12-03 | 1996-05-07 | Valleylab Inc. | Automatic bipolar control for an electrosurgical generator |
US5437664A (en) * | 1994-01-18 | 1995-08-01 | Endovascular, Inc. | Apparatus and method for venous ligation |
WO1995019148A1 (en) * | 1994-01-18 | 1995-07-20 | Endovascular, Inc. | Apparatus and method for venous ligation |
AU1076195A (en) * | 1994-01-31 | 1995-08-15 | Valleylab, Inc. | Telescoping bipolar electrode for non-invasive medical procedures |
US5868740A (en) * | 1995-03-24 | 1999-02-09 | Board Of Regents-Univ Of Nebraska | Method for volumetric tissue ablation |
US5817091A (en) * | 1997-05-20 | 1998-10-06 | Medical Scientific, Inc. | Electrosurgical device having a visible indicator |
-
1998
- 1998-01-09 US US09/005,288 patent/US6080149A/en not_active Expired - Lifetime
-
1999
- 1999-01-07 AU AU21087/99A patent/AU2108799A/en not_active Abandoned
- 1999-01-07 WO PCT/US1999/000424 patent/WO1999034743A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5423808A (en) * | 1991-11-08 | 1995-06-13 | Ep Technologies, Inc. | Systems and methods for radiofrequency ablation with phase sensitive power detection |
US5540681A (en) * | 1992-04-10 | 1996-07-30 | Medtronic Cardiorhythm | Method and system for radiofrequency ablation of tissue |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9050113B2 (en) | 2010-01-15 | 2015-06-09 | Medtronic Advanced Energy Llc | Electrosurgical devices, electrosurgical unit and methods of use thereof |
US9943356B2 (en) | 2010-01-15 | 2018-04-17 | Medtronic Advanced Energy Llc | Electrosurgical devices, electrosurgical unit and methods of use thereof |
Also Published As
Publication number | Publication date |
---|---|
US6080149A (en) | 2000-06-27 |
AU2108799A (en) | 1999-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6080149A (en) | Method and apparatus for monitoring solid tissue heating | |
AU738105B2 (en) | Method and system for heating solid tissue | |
US6685700B2 (en) | Method and system for heating solid tissue | |
US11937864B2 (en) | Ablation systems with parameter-based modulation and related devices and methods | |
EP1932487B1 (en) | Electrosurgical system employing multiple electrodes | |
US7167758B2 (en) | Medical instruments and techniques for treatment of gastro-esophageal reflux disease | |
US7942874B2 (en) | Apparatus for tissue cauterization | |
JP2647557B2 (en) | BPH resection method and device | |
JP5322266B2 (en) | Reflected power monitoring for microwave applications | |
EP0986336B1 (en) | System for performing plate type radiofrequency ablation | |
US20080234673A1 (en) | Multi-electrode instruments | |
US20070118110A1 (en) | Radio frequency lasso | |
EP2499982B1 (en) | Energy-based ablation completion algorithm | |
CA2762196A1 (en) | System for controlling tissue ablation using temperature sensors | |
JP2009018169A (en) | System and method for thermally profiling radiofrequency electrode | |
US5968041A (en) | Directable thermal energy delivery apparatus | |
US20030208193A1 (en) | Method and system for monitoring fluid temperature during arthroscopic electrosurgery | |
AU2006201357A1 (en) | Electrosurgical cannulas, systems and methods | |
US20230108832A1 (en) | Device for tissue treatment and method for electrode positioning | |
AU2014200393B2 (en) | Methods for control of energy delivery to multiple energy delivery devices |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP KR NZ |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: KR |
|
122 | Ep: pct application non-entry in european phase |